Top Holdings That Increased Gil Schwartzberg's Net Worth Over Years
Top Holdings That Increased Gil Schwartzberg's Net Worth Over Years

Top Holdings That Increased Gil Schwartzberg's Net Worth Over Years

Get details on Gil Schwartzberg's Top Holdings and Gil Schwartzberg Net Worth in the below article. Also, explore his trading performance.

Dr. Clemen Chiang
Dr. Clemen Chiang

The current estimated net worth of Lixte Biotechnology Holdings, Inc's Director, Gil Schwartzberg, is estimated to be about $203.82K. Gil Schwartzberg owns about 281,108 units of Lixte Biotechnology Holdings, Inc common stock. In the last 4 years at Lixte Biotechnology Holdings, Inc, Gil Schwartzberg has sold an estimated value of $0 worth.

What is Gil Schwartzberg's Past Insider Trading?

Gil Schwartzberg's largest purchase order was 105,264 units, worth over $500K on December 8, 2020. In total, Gil Schwartzberg has made about 4 transactions over 4 years of their time at Lixte Biotechnology Holdings, Inc. Gil Schwartzberg usually trades in December, April, January and July, with the busiest year in 2021.

Gil Schwartzberg Trading Performance

GuruFocus tracks the stock performance after each of Gil Schwartzberg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gil Schwartzberg is 29.66%. GuruFocus also compares Gil Schwartzberg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gil Schwartzberg within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

Insiders trading at Skechers U S A

Over the last 19 years, insiders at Skechers U S A have traded over $475,659,391 worth of Skechers U S A stock and bought 608,000 units worth $14,942,430 . The most active insiders traders include Robertgreenberg M Susangree..., Michael Greenberg, and Jeffrey Greenberg. On average, Skechers U S A executives and independent directors trade stock every 30 days with the average trade being worth of $2,282,700. The most recent stock trade was executed by Phillip Paccione on 7 December 2022, trading 561 units of SKX stock currently worth $24,084.
What does Skechers U S A do?

Based in Manhattan Beach, California, Skechers designs, develops and markets a diverse range of lifestyle and performance footwear, apparel and accessories for men, women and children. The Company's collections are available in the United States and over 170 countries and territories via department and specialty stores, and direct to consumers through 3,770 Company- and third-party-owned retail stores and e-commerce websites. The Company manages its international business through a network of global distributors, joint venture partners in Asia, Israel and Mexico, and wholly-owned subsidiaries in Canada, Japan, India, Europe and Latin America.

Gil Schwartzberg Owned Company Details

Skechers USA Inc(SKX)Lixte Biotech Holdings Inc(LIXT)

What does Skechers USA Inc do?

Skechers USA Inc is a lifestyle footwear company under the Skechers GO brand name. Products offered include various styles of women's shoes, men's shoes, girl's shoes, boy's shoes, performance shoes, and work shoes. Allied products offered are apparel, bags, eyewear, toys, and more. Its products are available for sale at department and specialty stores, athletic and independent retailers, boutiques, and internet retailers. The company's operating segments include Domestic Wholesale, International Wholesale, and Direct-to-Consumer. It generates maximum revenue from the International Wholesale segment.

Who are the key executives at Skechers USA Inc?

Gil Schwartzberg is the 10 percent owner of Skechers USA Inc. Other key executives at Skechers USA Inc include Chief Financial Officer John M Vandemore , Chief Marketing Officer Leonard Armato , and director & Chief Operating Officer David Weinberg .

Skechers USA Inc (SKX) Insider Trades Summary

Over the past 18 months, Gil Schwartzberg made no insider transaction in Skechers USA Inc (SKX). Other recent insider transactions involving Skechers USA Inc (SKX) include a net sale of 59,000 shares made by Jeffrey Greenberg , a net sale of 3,500 shares made by Katherine J. Blair , and a net sale of 1,302 shares made by Phillip Paccione .

In summary, during the past 3 months, insiders sold 2,061 shares of Skechers USA Inc (SKX) in total and bought 0 shares, with a net sale of 2,061 shares. During the past 18 months, 82,000 shares of Skechers USA Inc (SKX) were sold and 103,000 shares were bought by its insiders, resulting in a net purchase of 21,000 shares.

Skechers USA Inc (SKX)'s detailed insider trading history can be found in Insider Trading Tracker table.

YTD1Y3Y5Y10YAll

What does Lixte Biotech Holdings Inc do?

Lixte Biotech Holdings Inc is a drug discovery company that uses biomarker technology to identify enzyme targets associated with serious common diseases and then designs novel compounds to attack those targets. The company focuses on developing new treatments for human cancers for which therapies are urgently needed. It mainly designs drugs for which there are existing data suggesting any effect on altered pathways of the cancer cell and may be given safely to humans. The development program of the company includes drugs for the treatment of cancer, consisting of protein phosphatase inhibitors and histone deacetylase inhibitors.

Who are the key executives at Lixte Biotech Holdings Inc?

Gil Schwartzberg is the 10 percent owner of Lixte Biotech Holdings Inc. Other key executives at Lixte Biotech Holdings Inc include 10 percent owner Glenn Krinsky , Vice President and CFO Robert N Weingarten , and Chief Medical Officer James Miser .

Lixte Biotech Holdings Inc (LIXT) Insider Trades Summary

Over the past 18 months, Gil Schwartzberg made no insider transaction in Lixte Biotech Holdings Inc (LIXT). Other recent insider transactions involving Lixte Biotech Holdings Inc (LIXT) include a net purchase of 77,500 shares made by Rene Bernards , a net purchase of 41,112 shares made by Eric Forman , and a net purchase of 5,000 shares made by Regina Brown .

In summary, during the past 3 months, insiders sold 0 shares of Lixte Biotech Holdings Inc (LIXT) in total and bought 123,612 shares, with a net purchase of 123,612 shares. During the past 18 months, 0 shares of Lixte Biotech Holdings Inc (LIXT) were sold and 123,612 shares were bought by its insiders, resulting in a net purchase of 123,612 shares.

Lixte Biotech Holdings Inc (LIXT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Spiking Race to 100

We are extremely excited to announce we have a new product called Race to 100. You can track the best investors who have made more than 100% profit in a year and replicate their portfolios in just a few clicks. Be the first to learn these top investors' new trades and trade alongside the shoulders of the giants. Try Race to hundred now at spiking.com/race!

Join the Spiking Wealth Community

Want to learn more about the various trading strategies and see which one suits you the best? Led by Dr. Clemen Chiang, the Spiking Wealth Community is an online community network. Together we are catching the Spikes so that you have faith, hope, and love in everything you do. Spiking Wealth Community helps you to accomplish time squeeze by connecting the dots through online courses, live trading, winning trades, and more. Join us for Free and start your Spiking Wealth Journey today!

*Disclaimer: The article should not be taken as, and is not intended to provide investment advice. Claims made in this article do not constitute investment advice and should not be taken as such. Spiking strongly recommends that you perform your own independent research before making financial decisions